References
- Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302–45.10.1128/CMR.00111-13
- Dutronc H, Dauchy FA, Cazanave C, Rougie C, Lafarie-Castet S, Couprie B, et al. Candida prosthetic infections: case series and literature review. Scand J Infect Dis. 2010;42(11–12):890–5.10.3109/00365548.2010.498023
- Jakobs O, Schoof B, Klatte TO, Schmidl S, Fensky F, Guenther D, et al. Fungal periprosthetic joint infection in total knee arthroplasty: a systematic review. Orthop Rev (Pavia). 2015;7(1):5623. doi: 10.4081/or.2015.5623.
- Ueng SW, Lee CY, Hu CC, Hsieh PH, Chang Y. What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res. 2013;471(9):3002–9.10.1007/s11999-013-3007-6
- Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1–10.10.1093/cid/cis966
- Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, Chen SC, Eschenauer G, et al. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method. Antimicrob Agents Chemother. 2015;59(11):6725–32.10.1128/AAC.01250-15
- Mazzei T, Novelli A. Pharmacological properties of antifungal drugs with a focus on anidulafungin. Drugs. 2009;69(Suppl 1):79–90.10.2165/11315550-000000000-00000
- Marculescu CE, Cantey JR. Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res. 2008;466(6):1397–404.10.1007/s11999-008-0230-7
- Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis. 2002;34(7):930–8.10.1086/cid.2002.34.issue-7
- Reddy KJ, Shah JD, Kale RV, Reddy TJ. Fungal prosthetic joint infection after total knee arthroplasty. Indian J Orthop. 2013;47(5):526–9.10.4103/0019-5413.118213
- Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev. 2014;27(1):68–88.10.1128/CMR.00046-13
- Ripp SL, Aram JA, Bowman CJ, Chmielewski G, Conte U, Cross DM, et al. Tissue distribution of anidulafungin in neonatal rats. Birth Defects Res B Dev Reprod Toxicol. 2012;95(1):89–94.
- Theuretzbacher U. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Clin Microbiol Infect Dis. 2004;23(11):805–12.10.1007/s10096-004-1228-z
- Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother. 2008;52(1):357–60.10.1128/AAC.00856-07
- Liu P. Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections. Antimicrob Agents Chemother. 2013;57(1):466–74.10.1128/AAC.01473-12
- Kuiper JW, van den Bekerom MP, van der Stappen J, Nolte PA, Colen S. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop. 2013;84(6):517–23.10.3109/17453674.2013.859422
- Wang QJ, Shen H, Zhang XL, Jiang Y, Wang Q, Chen YS, Shao JJ. Staged reimplantation for the treatment of fungal peri-prosthetic joint infection following primary total knee arthroplasty. Orthop Traumatol Surg Res. 2015;101(2):151–6.10.1016/j.otsr.2014.11.014
- Deelstra JJ, Neut D, Jutte PC. Successful treatment of Candida albicans–infected total hip prosthesis with staged procedure using an antifungal-loaded cement spacer. J Arthroplasty. 2013;28(2):374.e5–8.10.1016/j.arth.2012.04.034
- Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.